http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2253711-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_634715a790f7ef0163a61e9f364bebcd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B57-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-04
filingDate 1997-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2005-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39ae81ce9ec4ceedefa20b7f1709a290
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aa4b17c769ced88078953c168851383
publicationDate 2005-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2253711-C
titleOfInvention Improved process for the production of enantiomerically-pure azetidine-2-carboxylic acid
abstract The invention relates to a process for the production of enantiomerically-pure AzeOH which comprises selective crystallisation of a diastereomerically-pure AzeOH-tartrate salt from a homogeneous solution of AzeOH, optically-active tartaric acid, an organic acid and an aldehyde, followed by liberation of the free amino acid.
priorityDate 1996-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7057884
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452718521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487659
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23681127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69263997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450447660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411320841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410697574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408499458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453213080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466

Total number of triples: 48.